Intervacc AB (publ) (STO:IVACC)
Sweden
· Delayed Price · Currency is SEK 1.010
+0.040 (4.12%)
Mar 28, 2025, 5:29 PM CET
Intervacc AB Revenue
In the year 2024, Intervacc AB had annual revenue of 11.79M SEK with 46.84% growth. Intervacc AB had revenue of 4.13M in the quarter ending December 31, 2024, with 153.81% growth.
Revenue
11.79M
Revenue Growth
+46.84%
P/S Ratio
6.49
Revenue / Employee
785.80K
Employees
15
Market Cap
344.22M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.79M | 3.76M | 46.84% |
| Dec 31, 2023 | 8.03M | -4.33M | -35.01% |
| Dec 31, 2022 | 12.35M | 3.43M | 38.43% |
| Dec 31, 2021 | 8.92M | 1.91M | 27.20% |
| Dec 31, 2020 | 7.02M | -7.41M | -51.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.30B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.29B |
| Elekta AB | 17.88B |